Dongning Huang

机构：Chongqing University, Liuzhou Maternal and Child Health Hospital, Liuzhou General Hospital, Fourth Affiliated Hospital of Guangxi Medical University, Liaoning Cancer Hospital & Institute, China Medical University · ORCID：0000-0001-8075-4264

发表论文 24 篇 · 总被引 288 次 · h-index 8

代表论文

• Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study (2023 · The Lancet Respiratory Medicine · 被引 75)
• Targeting Lung Cancer Stem Cells with Antipsychological Drug Thioridazine (2016 · BioMed Research International · 被引 40)
• Integrated Analysis and Finding Reveal Anti–Liver Cancer Targets and Mechanisms of Pachyman (Poria cocos Polysaccharides) (2021 · Frontiers in Pharmacology · 被引 33)
• Integrated analysis of clinical significance and functional involvement of microRNAs in hepatocellular carcinoma (2019 · Journal of Cellular Physiology · 被引 28)
• Nucleotide excision repair gene polymorphisms and prognosis of non-small cell lung cancer patients receiving platinum-based chemotherapy: A meta-analysis based on 44 studies (2014 · Biomedical Reports · 被引 25)
• A Phase III, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer – The FALUCA study (2020 · Lung Cancer · 被引 21)